Most Common Adverse Reactions with
DYANAVEL XR Tablet From Phase 3 Study1
may PAY $25 for
Tris ADHD products
Most Commonly Reported Adverse Reactions (>5%) in the DYANAVEL XR Tablet Group and Greater Than Placebo1


- No serious adverse reactions were reported in this double-blind, forced dose–titration study2
— Three subjects in the DYANAVEL XR (amphetamine) group discontinued treatment due to adverse reactions1 - A forced dose–titration study method may increase the number and percentage of adverse reactions. Clinicians can titrate the dose to maximize efficacy and minimize side effects3
PK, pharmacokinetic.
References: 1. Data on file. Tris Pharma, Inc. 2. Cutler AJ, Pardo A, King TR, Rafla E, Duhoux S, Kando JC. Poster presented at: The American Professional Society of ADHD and Related Disorders; January 15-17, 2021; virtual conference. 3. Farhat LC, Flores JM, Behling E, et al. Mol Psychiatry. 2022;27(3):1562-1572.